Welcome

to the Chiesi CEE Group!

Chiesi Pharmaceuticals, Vienna based, a member of the Chiesi Corporation, Italy, the regional center for Central and Eastern Europe and the Commonwealth of Independent States.

more about Chiesi Central Eastern Europe

THERAPEUTIC AREAS

Rheumatology

Piroxicam-Betadex is a molecule developed by Chiesi based on a chemical complex (host-guest technology) in which every piroxicam molecule is enclosed in a sugar ring. This formulation yields a significant improvement in terms and resorption and, therefore, the onset of action. The portfolio of rheumatological products is being expanded through the addition of a hyaluronic acid preparation (NeoVisc®) and a modern anti-rheumatic therapy (Orthokine®).

go to Therapeutic Areas